Does the CPCA apply to every nitrosamine?
Author : first copy | Published On : 18 Nov 2026
No, the Carcinogenic Potency Categorization Approach (CPCA) does not apply to every nitrosamine impurity. It is mainly used to estimate the carcinogenic potency and establish Acceptable Intake (AI) limits for eligible N-nitrosamine impurities when sufficient compound-specific carcinogenicity data is not available. The approach evaluates the chemical structure, alpha-hydrogen atoms, and activating or deactivating structural features to assign the impurity to one of five potency categories.
However, CPCA is not required when reliable compound-specific toxicological data or an appropriate read-across assessment is available to establish an AI limit. It is also not applicable to certain other N-nitroso compounds, such as nitrosamides and nitrosamines with different structural features outside the method's scope. Proper Nitrosamine Impurity Testing, scientific risk assessment, and professional Nitrosamine Testing Services help pharmaceutical manufacturers identify and control Nitrosamine Impurities in Pharmaceuticals while ensuring compliance with applicable FDA and EMA guidelines.
Read the full guide: https://www.molkem.com/blog/nitrosamine-acceptable-intake-limits
